C
CGEM icon

Covestor’s Cullinan Oncology CGEM Stock Holding History

Covestor’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
33
+23
+230% +$342 ﹤0.01% 2083
2026
Q1 		$0 Sell
10
-33
-77% -$424 ﹤0.01% 2308
2025
Q4 		$0 Buy
43
+33
+330% +$298 ﹤0.01% 2307
2025
Q3 		$0 Hold
10
– – ﹤0.01% 2326
2025
Q2 		$0 Buy
10
+5
+100% +$40 ﹤0.01% 2254
2025
Q1 		$0 Hold
5
– – ﹤0.01% 2269
2024
Q4 		$0 Buy
5
+1
+25% +$14 ﹤0.01% 2277
2024
Q3 		$0 Sell
4
-1
-20% -$18 ﹤0.01% 2265
2024
Q2 		$0 Buy
+5
New +$106 ﹤0.01% 2275
2023
Q4 		– Sell
-123
Closed -$1K – 2185
2023
Q3 		$1K Buy
+123
New +$1.28K ﹤0.01% 1902

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Covestor's CGEM Position: Q2 2026 in Review

Covestor increased its Cullinan Oncology (CGEM) stake by 230% in Q2 2026, buying an estimated $342 and bringing the position to 33 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Covestor first reported a position in CGEM in Q3 2023 and has held it in 10 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Covestor held 33 shares of Cullinan Oncology worth $1K as of Q2 2026.
  • Covestor bought 23 Cullinan Oncology shares in Q2 2026, an estimated $342.
  • Cullinan Oncology made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2083 holding.
  • Covestor first reported a position in Cullinan Oncology in Q3 2023 and has held it in 10 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.